My research is divided into four areas: (1) virus-induced cancer (gamma-2 herpesvirus and hepatitis B virus); (2) emerging virus: mosquito-borne flavivirus (Dengue virus and Zika virus), tick-borne bunyavirus (Severe Fever with Thrombocytopenia virus and Heartland virus) and air-borne virus (severe acute respiratory syndrome coronavirus 2 and influenza virus); (3) therapeutic/vaccine development and stabilization, and (4) inflammation and immunity (host-pathogen standoff, programmed cell death, immune atlas of pregnancy and inflammation). The overarching goal of my research is to uncover new ways to understand infection and immunity and to rapidly develop and distribute vaccines and therapeutics to improve global health.

Currently, two Post-Doc positions are open in research for 1) Antibody and structural biology field and 2) Cell therapy field

 

Jae Jung, PhD

Director, Global Center for Pathogen & Human Health Research

Department Chair, Cancer Biology

Director, Infection Biology

Betsy B. deWindt Endowed Chair in Cancer Biology

Email: jungj@ccf.org

Location: Cleveland Clinic Main Campus